Related Experiment Video
Updated: Jan 23, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
LncRNA FENDRR attenuates colon cancer progression by repression of SOX4 protein
1Department of Gastroenterological Surgery, Liaocheng People's Hospital, Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong Province, 252000, People's Republic of China.
Abstract:
Background and purpose: Homo sapiens FOXF1 adjacent noncoding developmental regulatory RNA (FENDRR) is a novel long noncoding RNA (lncRNA) exerting important effects on transcriptional and post-transcriptional regulation. The purpose of this study was to investigate the potential role of FENDRR in colon cancer. Methods: Multiple cellular and molecular biology experiments were performed in the present study, such as CCK-8, Western blot, immunohistochemistry, confocal immunofluorescent and animal studies. Results: We determined that attenuation of FENDRR was a frequent event in colon cancer tissues and colon cancer cell lines, in contrast to their normal counterparts. Low levels of FENDRR were associated with the clinical stages and poor prognosis. Moreover, ectopic expression of FENDRR repressed colon cancer cell viability, invasion and epithelial-mesenchymal transition. Furthermore, through a series of in vitro and in vivo assays, we reported the discovery of FENDRR modulating the expression of SOX4 protein, and hence in the progression of colon cancer. Conclusion: Based on these data, we demonstrated that FENDRR may function as a tumor-suppressor gene by repressing SOX4 and as a potential therapeutic target for colon cancer.
Insights
FENDRR, a long noncoding RNA, is frequently reduced in colon cancer. Lower FENDRR levels correlate with advanced stages and poor prognosis, suggesting its tumor-suppressive role.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long noncoding RNAs (lncRNAs) play critical roles in gene regulation.
- FENDRR (Homo sapiens FOXF1 adjacent noncoding developmental regulatory RNA) is a novel lncRNA involved in transcriptional and post-transcriptional regulation.
- The role of FENDRR in colon cancer remains largely unexplored.
Purpose of the Study:
- To investigate the function and clinical significance of FENDRR in colon cancer.
- To determine FENDRR's impact on colon cancer cell behavior and progression.
- To elucidate the molecular mechanism underlying FENDRR's action in colon cancer.
Main Methods:
- Analysis of FENDRR expression in colon cancer tissues and cell lines.
- Cellular assays including CCK-8, invasion assays, and epithelial-mesenchymal transition (EMT) assessment.
- Molecular techniques such as Western blot, immunohistochemistry, and confocal immunofluorescence.
- In vitro and in vivo animal studies to validate findings.
- Investigation of FENDRR's interaction with SOX4 protein.
Main Results:
- FENDRR expression is significantly attenuated in colon cancer tissues and cell lines compared to normal controls.
- Low FENDRR levels are associated with advanced clinical stages and predict poor patient prognosis.
- Re-expression of FENDRR inhibits colon cancer cell viability, invasion, and EMT.
- FENDRR modulates SOX4 protein expression, impacting colon cancer progression.
- In vitro and in vivo experiments confirm FENDRR's regulatory role in colon cancer.
Conclusions:
- FENDRR acts as a tumor suppressor in colon cancer by inhibiting SOX4.
- FENDRR downregulation is a significant event in colon cancer development and progression.
- FENDRR represents a potential therapeutic target for colon cancer treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Repressed Memory
The Colonization of Land

